Tag: dermatology

LLR Policy for Treatment for Facial Hyper Pigmentation

Category Threshold Criteria Hyperpigmentation results in flat, darkened patches of skin that can vary in size and colour. Pigment spots such as age spots are caused by sun exposure. For […]

LLR Policy for Hair Depilation for Excessive Growth (Hirsutism)

The LLR  ICB do NOT ROUTINELY FUND this treatment. However the treatment will be funded in the following circumstances The INDIVIDUAL FUNDING REQUEST process, forms and guidance are available via […]

LLR Policy for Hair Transplantation

The LLR  ICB do NOT ROUTINELY FUND this treatment. However the treatment will be funded in the following circumstances The INDIVIDUAL FUNDING REQUEST process, forms and guidance are available via […]

LLR Policy for Laser Treatment

Category Threshold Criteria Laser therapy can be used to treat skin conditions by targeting intense light energy into your skin to reduce the appearance of abnormal vessels. Eligibility LLR ICB […]

LLR Policy for  Photo-destruction of Electrolysis Lesion of Skin

The LLR  ICB do NOT ROUTINELY FUND this treatment. However the treatment will be funded in the following circumstances The INDIVIDUAL FUNDING REQUEST process, forms and guidance are available viaPRISM, […]

LLR Policy for Rhinophyma

Category Threshold Criteria Rhinophyma is a skin disorder characterised by a large, red, bumpy nose. It can occur as part of a phymatous rosacea. The exact cause is not known […]

LLR Policy for Alopecia

Category Threshold Criteria Alopecia is the general medical term for hair loss. There are several types of hair loss with different symptoms and causes. Male and female pattern baldness This […]

LLR Policy for Alopecia

Threshold Criteria Alopecia is the general medical term for hair loss. There are several types of hair loss with different symptoms and causes. Male and female pattern baldness This is […]

LLR Policy for Actinic Keratosis

Threshold Criteria Actinic keratosis (AK) is a common sun induced scaly or hyperkeratotic lesion which has the potential to become malignant. NICE estimates that over 23% of the UK population […]